JARDYMET EMPAGLIFLOZIN 12.5MG/METFORMIN 500MG TABLETS 28’S

Jardymet is a prescription medication that combines two active ingredients: Empagliflozin (12.5 mg) and Metformin (500 mg). This medication is primarily used for the management of type 2 diabetes mellitus in adults. Empagliflozin is an SGLT2 inhibitor that helps lower blood sugar levels by preventing glucose reabsorption in the kidneys, while Metformin is a biguanide that improves insulin sensitivity and reduces hepatic glucose production.

Together, these components work synergistically to enhance glycemic control, making Jardymet an effective option for patients who need additional help managing their blood sugar levels. It is often prescribed when diet and exercise alone are insufficient. Additionally, Jardymet may help reduce the risk of cardiovascular events in patients with type 2 diabetes. In Kenya, it is important for patients to consult healthcare professionals for personalized diabetes management plans.